E-ISSN 2636-834X
 

Original Research 


Treatment adherence in bipolar disorder

Haluk A. Savaş, Ahmet Unal, Osman Vırıt.

Cited by (4)

Abstract
Purpose: A high level of treatment adherence is essential in patients with bipolar disorder for effective treatment, due to chronic progressive nature of the illness requiring maintenance treatment. Treatment nonadherence in individuals with bipolar disorder is the main reason for relapse and recurrence. The purpose of this study is to investigate the relationship between treatment adherence and the level of medication treatment adherence in the last month, socio-demographic and clinic characteristics affecting adherence, and the number of follow-up examinations within the last year in euthymic bipolar patients who registered at a psychiatry outpatient clinic at least a year ago.

Method: The sample group of this study comprised of 147 euthymic patients, aged over 18, who visited the Psychiatry Outpatient Clinic of Malatya State Hospital, and diagnosed with a Bipolar Disorder in accordance with DSM-IV, and had been monitored at the clinic for at least a year because of this diagnosis. The hospital records were examined simultaneously for patients attending their follow-up examinations between 02.01.2011 and 02.28.2011. The patients, who had computerized records as of February 01, 2010, were included in this study, and their number of follow-up examinations was obtained from hospital records. The information regarding participating patients’ demographic variables, clinical properties, and their attitude towards their illness and treatment were recorded in the Data Gathering Form. The patients were categorized in two groups; those that had taken their medication or taken it irregularly for less than seven days within the last month were categorized as “treatment adherent,” and those that had not taken their medication or taken it irregularly for more than seven days within the last month were categorized as “treatment nonadherent.” SPSS 16.0 was used for the statistical data analysis. The data of treatment adherent group was compared to the data of treatment nonadherent group.

Results: 108 (73.5%) patients were treatment adherent, while 39 (26.5%) patients were treatment nonadherent. The level of education (based on 8 years) was higher in the treatment adherent group (p<0.001). The rate of hospitalization was lower in the treatment adherent group in comparison to the treatment nonadherent group (p<0.05). The rate of attending to follow-up examinations within the last year (t= -5.42) and the level of insight towards their illness was higher in the treatment adherent group (p<0.001). There was no difference between the two groups in terms of their present medication or drug combinations (p>0.05). The treatment adherent group believed that they were more informed about their illness and treatment in comparison to the nonadherent group (p<0.001). The treatment nonadherent group believed that treatment had no effect on their disorder more than the treatment adherent group (p<0.05); the rate of disregarding medication because they thought they had

Key words: Pregnancy, antidepressant safety, teratogenicity, untreated depression


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Haluk A. Savaş
Articles by Ahmet Unal
Articles by Osman Vırıt
on Google
on Google Scholar


REFERENCES
1. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol Clin Exp 2008; 23:95-105. [DOI via Crossref]    [Pubmed]   
2. El-Mallakh RS. Medication adherence and the use of long-acting antipsychotics in bipolar disorder. Journal of Psychiatric Practice 2007;13(2):79-85. [DOI via Crossref]    [Pubmed]   
3. Üstünsoy Çobanoðlu ZS, Aker T, Çobanoðlu N. Þizofreni ve diðer psikotik bozukluðu olan hastalarda tedaviye uyum sorunlarý. Düþünen Adam 2003;16:211-218.
4. Sajatovic M, Velligan DI, Weiden, Valenstein MA, Ogedegbe G. Measurment of psychiatric treatment adherence. Journal of Psychosomatic Research 2010;69:591-599. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
5. Sajatovic M, Biswas K, Kilbourne AK, Fenn H, Williford W, Bauer MS. Factors associated with prospective long-term treatment adherence among individuals with bipolar disorder. Psychiatric Services 2008;59:753-759. [DOI via Crossref]    [Pubmed]   
6. Lingam R, Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 2002;105:164-172. [DOI via Crossref]   
7. Kessing LV, Hansen HV, Bech P. Attitudes and beliefs among patients treated with mood stabilizers. Clinical Practice and Epidemiology in Mental Health 2006;2-8.
8. Suppers T, Baldessarini RJ, Faedda GL. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 1991;48:1082-1088. [DOI via Crossref]   
9. Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, Blow FC. Predictors of nonadherence among individuals with bipolar disorder receiving tratment in a community mental health clinic. Comprehensive Psychiatry. 2009;50:100-107. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
10. Scott J. Predicting medication non-adherence in severe affective disorders. Acta Neuropsychiatrica 2000;12:128-130.
11. Sajatovic M, Davies M, Hrouda DR. Enhancement of treatment adherence among patients with bipolar disorder. Psychiatric Services 2004;55:264-269. [DOI via Crossref]    [Pubmed]   
12. Scott J, Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels and psychiatric hospitilization. Am J Psychiatry 2002;159:1927-1929. [DOI via Crossref]   
13. Jonsdottir H, Opjordsmoen S, Birkenaes A, Engh JA, Ringen PA, Vaskinn A, Aamo TO, Friis S, Andreassen OA. Medication adherence in outpatients with severe mental disorders: relation between self-reports and serum level. Journal of Clinical Psychopharmacology 2010;30:169-175. [DOI via Crossref]    [Pubmed]   
14. Sturman ED, Sproule BA. Toward the development of a mood disorders insight scale: modification of Birchwood&#8217;s psychosis insight scale. J Affect Disord 2003;77:21-30. [DOI via Crossref]   
15. Colom F, Vieta E, Martinez-Aran A, Reinares M, Benabarre A, Gasto C. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clin Psychiatry 2000;61:549-555. [DOI via Crossref]    [Pubmed]   
16. Johnson LS, Fulford D. Development of the treatment attitudes questionnaire in bipolar disorder. J Clin Psychol 2008;64:466-481. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
17. Sajatovic M, West JA, Meyer WJ, Cassidy KA, Lamkin N, Calabrase JR, Jenkins JH. Subjective aspects of medication treatment and medication adherence among individuals with bipolar disorder. New Research in Mental Health volüm 18:324-332.
18. Sajatovic M, Bauer MS, Kilbourne AM, Vertrees JE, Williford W. Self-Reported medication treatment adherence among veterans with bipolar disorder. Psychiatric Services 2006;57:56-62. [DOI via Crossref]    [Pubmed]   
19. Copeland LA, Zeber JE, Salloum IM. Treatment adherence and illness insight in veterans with bipolar disorder. J Nerv Ment Dis 2008;196:16-21. [DOI via Crossref]    [Pubmed]   
20. Samalin L, Charpeaud T, Lorabi O, Liorca PM. Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection. Patient Prefer Adherence 2010;4:325-334. [Pubmed]    [PMC Free Fulltext]   
21. Bates JA, Whitehead R, Bolge SC, Kim E. Correlates of medication adherence among bipolar disorder: Results of the bipolar evaluation of satisfaction and tolerability (BEST) study: A nationwide cros-sectional survey. Prim Care Companion J Clin Psychiatry 2010;12:1-10.
22. Kessing LV, Hansen HV, Bech P. Attitudes and beliefs among patients treated with mood stabilizers. Clinical Practice and Epidemiology in Mental Health 2006;2:8. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
23. Sajatovic M, Levin J, Fuentes-Cassino E, Cassidy KA, Tatsuoka C, Jenkins JH. Illnes experience and reasons for nonadherence among individuals with bipolar disorder who are poorly adherent with medication. Compr Psychiatry 2011;52:280-287. [DOI via Crossref]    [Pubmed]    [PMC Free Fulltext]   
24. Swartz M, Swanson J, Hiday V, Borum R, Wagner H, Burns B. Violence and severe mental illness: The effects of substance misuse and non-adherence to medication. Am J Psychiatry 1998;155:226-231. [Pubmed]   
25. Littlejohn R, Leslie F, Cookson J. Depot antipsychotics in the prophylaxis of bipolar affective disorder. Br J Psychiatry 1994;165:827-829. [DOI via Crossref]    [Pubmed]   
26. Basoglu C, Gecici O, Ates MA, Semiz UB, Algül A, Ebrinc S, Cetin M. Efficacy and safety of long-acting injectable risperidone during treatment of manic episode with non-compliance bipolar patients. Neurology Psychiatry and Brain Research 2008;15:39-44.
27. Savas HA, Yumru M, Ozen ME. Use of long-acting risperidon in the treatment of bipolar patients. J Clin Psychopharmacol 2006;26:530-531. [DOI via Crossref]    [Pubmed]   

This Article Cited By the following articles

Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis
Syst Rev 2020; 9(1): .

1
 
Treatment Attitudes and Adherence Among Patients with Bipolar Disorder
Harvard Review of Psychiatry 2019; 27(5): 290.

2
 
Medication non-adherence in bipolar disorder: Review of rates, demographic and clinical predictors
WJMA 2017; 5(4): 103.

3
 
Treatment-adherence in bipolar disorder: A patient-centred approach
WJP 2016; 6(4): 399.

4
 
How to Cite this Article
Pubmed Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. Treatment adherence in bipolar disorder. PBS. 2011; 1(3): 95-102. doi:10.5455/jmood.20110827015615


Web Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. Treatment adherence in bipolar disorder. http://www.pbsciences.org/?mno=12078 [Access: September 28, 2021]. doi:10.5455/jmood.20110827015615


AMA (American Medical Association) Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. Treatment adherence in bipolar disorder. PBS. 2011; 1(3): 95-102. doi:10.5455/jmood.20110827015615



Vancouver/ICMJE Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. Treatment adherence in bipolar disorder. PBS. (2011), [cited September 28, 2021]; 1(3): 95-102. doi:10.5455/jmood.20110827015615



Harvard Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt (2011) Treatment adherence in bipolar disorder. PBS, 1 (3), 95-102. doi:10.5455/jmood.20110827015615



Turabian Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. 2011. Treatment adherence in bipolar disorder. Psychiatry and Behavioral Sciences, 1 (3), 95-102. doi:10.5455/jmood.20110827015615



Chicago Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. "Treatment adherence in bipolar disorder." Psychiatry and Behavioral Sciences 1 (2011), 95-102. doi:10.5455/jmood.20110827015615



MLA (The Modern Language Association) Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt. "Treatment adherence in bipolar disorder." Psychiatry and Behavioral Sciences 1.3 (2011), 95-102. Print. doi:10.5455/jmood.20110827015615



APA (American Psychological Association) Style

Haluk A. Savaş, Ahmet Unal, Osman Vırıt (2011) Treatment adherence in bipolar disorder. Psychiatry and Behavioral Sciences, 1 (3), 95-102. doi:10.5455/jmood.20110827015615